Evonik announced today that it has acquired German biotech company JeNaCell, expanding its biomaterials portfolio with the startup’s biotechnologically derived cellulose. JeNaCell’s biomaterial is ...
Evonik has acquired the German biotech company JeNaCell, expanding its biomaterials portfolio. Evonik has reported, in an Aug. 2, 2021 press release, that it has acquired the German biotech company ...
Nanostructured biomaterial for wound dressings and dermatology to be integrated into Health Care business Evonik Venture Capital’s early investment in 2015 pays off Evonik aims to more than double the ...
Evonik has purchased the German start-up JeNaCell, which makes biotechnologically derived cellulose for medical applications. Evonik’s venture capital arm invested in JeNaCell in 2015 and now plans to ...
Biosynthetic cellulose offers potential for applications such as wound dressings, implantable materials, and drug-delivery systems. In 2016, German biotech company JeNaCell GmbH devised means for ...
(MENAFN- Evonik Leading Beyond Chemistry) Jena, Germany. Evonik has signed an agreement with the medical technology consulting and sales company Coopmed for the distribution of the wound dressing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results